Skip to content

Arrowhead Research ARWR Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on available-for-sale securities at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's unrealized gains (losses) on available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's unrealized gains (losses) on available-for-sale securities?
Arrowhead Research (ARWR) reported unrealized gains (losses) on available-for-sale securities of -$6.93M in Q1 2026.
How has Arrowhead Research's unrealized gains (losses) on available-for-sale securities changed year-over-year?
Arrowhead Research's unrealized gains (losses) on available-for-sale securities decreased by 1161.9% year-over-year, from $653K to -$6.93M.
What does unrealized gains (losses) on available-for-sale securities mean?
Changes in the market value of investment securities that the company still holds.
How do you interpret unrealized gains (losses) on available-for-sale securities?
Positive values indicate market appreciation of held assets, while negative values indicate market depreciation.
How does unrealized gains (losses) on available-for-sale securities compare across companies?
Common for companies with significant cash reserves invested in marketable securities.